A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
The aim of this trial is to investigate whether pre-operative treatment with chemotherapy plus radiation therapy has a better outcome than chemotherapy alone in patients undergoing surgery for resectable gastric cancer.
Primary Sponsor
Collaborating Groups
TROG Cancer Research; Canadian Cancer Trial Group (CCTG); European Organisation for Research & Treatment of Cancer (EORTC); National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC)
Accrual Target
570
Expected Date of Accrual
31 December 2020
Trial Chairperson
Professor Trevor Leong, Peter MacCallum Cancer Centre, VIC
Trial Contact
topgear@ctc.usyd.edu.au
Related Post
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
